Search

Reginald A. Renwick

Examiner (ID: 15419, Phone: (571)270-1913 , Office: P/3714 )

Most Active Art Unit
3715
Art Unit(s)
3715, 3714
Total Applications
1008
Issued Applications
720
Pending Applications
71
Abandoned Applications
234

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19111214 [patent_doc_number] => 20240122964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN [patent_app_type] => utility [patent_app_number] => 18/541398 [patent_app_country] => US [patent_app_date] => 2023-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541398 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/541398
COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN Dec 14, 2023 Pending
Array ( [id] => 19142243 [patent_doc_number] => 20240141073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 18/494749 [patent_app_country] => US [patent_app_date] => 2023-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/494749
METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE Oct 24, 2023 Pending
Array ( [id] => 20320094 [patent_doc_number] => 20250332182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => Galactooligosaccharides for improving immune response [patent_app_type] => utility [patent_app_number] => 18/557304 [patent_app_country] => US [patent_app_date] => 2023-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557304 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/557304
Galactooligosaccharides for improving immune response May 2, 2023 Pending
Array ( [id] => 18496110 [patent_doc_number] => 20230218654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES [patent_app_type] => utility [patent_app_number] => 18/181016 [patent_app_country] => US [patent_app_date] => 2023-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181016 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/181016
COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES Mar 8, 2023 Pending
Array ( [id] => 18449576 [patent_doc_number] => 20230190852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => COMPOSITIONS AND METHODS FOR JOINT HEALTH [patent_app_type] => utility [patent_app_number] => 18/113370 [patent_app_country] => US [patent_app_date] => 2023-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18113370 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/113370
COMPOSITIONS AND METHODS FOR JOINT HEALTH Feb 22, 2023 Pending
Array ( [id] => 18535214 [patent_doc_number] => 20230240295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHOD OF AND A COMPOSITION FOR PROTECTING PLANTS AGAINST PLANT PATHOGENS [patent_app_type] => utility [patent_app_number] => 18/084399 [patent_app_country] => US [patent_app_date] => 2022-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3697 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084399 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/084399
METHOD OF AND A COMPOSITION FOR PROTECTING PLANTS AGAINST PLANT PATHOGENS Dec 18, 2022 Abandoned
Array ( [id] => 18294205 [patent_doc_number] => 20230103891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => DRUG-LOADED NANOPARTICLES FOR HEPATIC ARTERY CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/074561 [patent_app_country] => US [patent_app_date] => 2022-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3114 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074561 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/074561
DRUG-LOADED NANOPARTICLES FOR HEPATIC ARTERY CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF Dec 4, 2022 Abandoned
Array ( [id] => 18391694 [patent_doc_number] => 20230159912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => COMPOSITIONS AND METHODS FOR NUCLEIC ACID NORMALIZATION [patent_app_type] => utility [patent_app_number] => 17/993150 [patent_app_country] => US [patent_app_date] => 2022-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993150 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/993150
COMPOSITIONS AND METHODS FOR NUCLEIC ACID NORMALIZATION Nov 22, 2022 Pending
Array ( [id] => 18349294 [patent_doc_number] => 20230137405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL [patent_app_type] => utility [patent_app_number] => 18/050799 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050799 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/050799
COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL Oct 27, 2022 Pending
Array ( [id] => 18339171 [patent_doc_number] => 20230131120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHODS FOR BODY WEIGHT CONTROL USING THIOLATED CHITOSANS [patent_app_type] => utility [patent_app_number] => 17/971753 [patent_app_country] => US [patent_app_date] => 2022-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971753 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/971753
METHODS FOR BODY WEIGHT CONTROL USING THIOLATED CHITOSANS Oct 23, 2022 Abandoned
Array ( [id] => 18497697 [patent_doc_number] => 20230220372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => USE OF MIXTURES OF POLYVINYLPYRROLIDONE AND AMMONIUM SULFATE IN THE ISOLATION OF NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 17/961255 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7034 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/961255
USE OF MIXTURES OF POLYVINYLPYRROLIDONE AND AMMONIUM SULFATE IN THE ISOLATION OF NUCLEIC ACIDS Oct 5, 2022 Pending
Array ( [id] => 18311339 [patent_doc_number] => 20230115239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => BIOCOMPATIBLE SCAFFOLD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/960972 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960972 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/960972
BIOCOMPATIBLE SCAFFOLD AND USE THEREOF Oct 5, 2022 Pending
Array ( [id] => 18453236 [patent_doc_number] => 20230194516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHOD FOR IMMOBILIZING NUCLEIC ACID COMPOUND, REAGENT KIT, AND SENSOR [patent_app_type] => utility [patent_app_number] => 17/930412 [patent_app_country] => US [patent_app_date] => 2022-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930412 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/930412
METHOD FOR IMMOBILIZING NUCLEIC ACID COMPOUND, REAGENT KIT, AND SENSOR Sep 6, 2022 Pending
Array ( [id] => 18269449 [patent_doc_number] => 20230090691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => COMPOSITIONS AND METHODS FOR PROMOTING AND/OR MAINTAINING VAGINOVULVAL AND PERIANAL TISSUE VITALITY AND TISSUE HEALTH [patent_app_type] => utility [patent_app_number] => 17/900606 [patent_app_country] => US [patent_app_date] => 2022-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17900606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/900606
COMPOSITIONS AND METHODS FOR PROMOTING AND/OR MAINTAINING VAGINOVULVAL AND PERIANAL TISSUE VITALITY AND TISSUE HEALTH Aug 30, 2022 Pending
Array ( [id] => 18107976 [patent_doc_number] => 20230000856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => NOVEL USES OF CRENOLANIB [patent_app_type] => utility [patent_app_number] => 17/897861 [patent_app_country] => US [patent_app_date] => 2022-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17897861 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/897861
NOVEL USES OF CRENOLANIB Aug 28, 2022 Abandoned
Array ( [id] => 18612244 [patent_doc_number] => 20230278976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Synthesis Of Beta-Glycolipid Compounds [patent_app_type] => utility [patent_app_number] => 17/858059 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/858059
Synthesis Of Beta-Glycolipid Compounds Jul 4, 2022 Abandoned
Array ( [id] => 17928350 [patent_doc_number] => 20220323475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => COMBINATION THERAPY FOR CANCER [patent_app_type] => utility [patent_app_number] => 17/844691 [patent_app_country] => US [patent_app_date] => 2022-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12476 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844691
COMBINATION THERAPY FOR CANCER Jun 19, 2022 Abandoned
Array ( [id] => 19316778 [patent_doc_number] => 20240238318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/559204 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559204 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/559204
L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER May 5, 2022 Pending
Array ( [id] => 18266752 [patent_doc_number] => 20230087994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => TARGETED BIFUNCTIONAL DEGRADERS [patent_app_type] => utility [patent_app_number] => 17/654990 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 447 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654990 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/654990
TARGETED BIFUNCTIONAL DEGRADERS Mar 14, 2022 Abandoned
Array ( [id] => 19345193 [patent_doc_number] => 20240254156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => NOVEL ISOFLAVONE COMPOUND [patent_app_type] => utility [patent_app_number] => 18/564287 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564287 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564287
NOVEL ISOFLAVONE COMPOUND Mar 13, 2022 Pending
Menu